$8.86 0.00 (%) Affymetrix Inc - NASDAQ

Nov. 21, 2014 | 04:00 PM

Partner Headlines

  1. Affymetrix And Ariosa Diagnostics Announce Signing Of Multi-Year Supply Agreement In Support Of Ariosa's Non-Invasive Prenatal Test

    Benzinga | Oct. 16, 2014 | 07:09AM EST
  2. UPDATE: BTIG Initiates Coverage On Affymetrix, Inc.

    Benzinga | Oct. 3, 2014 | 08:56AM EST
  3. A Few Medical Research Stocks Break Out, Others Basing

    IBD | Jun. 9, 2014 | 18:53PM EST
  4. US Stock Futures Edge Higher Ahead Of Jobless Claims Report

    Benzinga | May. 8, 2014 | 07:45AM EST
  5. UPDATE: Bank of America Reiterates On Affymetrix As Growth/Profitability Improve

    Benzinga | May. 2, 2014 | 08:17AM EST
  6. Enzo Biochem Announces $5.1M Settlement Agreement with Affymetrix

    Benzinga | Apr. 24, 2014 | 09:50AM EST
  7. Mid-Afternoon Market Update: Yelp Shares Show Strength as Pandora Continues to Fall on Poor Guidance

    Benzinga | Feb. 6, 2014 | 15:29PM EST
  8. Mid-Day Market Update: Green Mountain Coffee Shares Jump After Coca-Cola Deal; Twitter Falls

    Benzinga | Feb. 6, 2014 | 12:36PM EST
  9. Mid-Morning Market Update: Markets Rise; General Motors Earnings Miss Estimates

    Benzinga | Feb. 6, 2014 | 10:26AM EST
  10. Morgan Stanley Focuses on 2014 Outlook for Affymetrix

    Benzinga | Feb. 6, 2014 | 08:42AM EST
  11. AFFYMETRIX

    IBD | Feb. 5, 2014 | 18:45PM EST
  12. Affymetrix Receives FDA Clearance to Market CytoScan Dx Assay

    Benzinga | Jan. 21, 2014 | 06:04AM EST
  13. Affymetrix Announces Collaboration with University of Bristol on Genotyping Arrays

    Benzinga | Jan. 13, 2014 | 05:42AM EST
  14. Mid-Afternoon Market Update: Markets Post Large Rally as Textron Falls on Citron Report

    Benzinga | Jan. 7, 2014 | 15:43PM EST
  15. Affymetrix Announces Q4 2013 Revenue of Approximately $91M, FY 2013 Revenue of Approximately $329M

    Benzinga | Jan. 7, 2014 | 06:06AM EST
  16. Shares of Affymetrix Respond to Morgan Stanley Downgrade

    Benzinga | Jan. 6, 2014 | 11:44AM EST
  17. Affymetrix Announces Microarray for Identifying and Subtyping Pathogenic E. coli Using Unique DNA Signatures

    Benzinga | Nov. 12, 2013 | 06:37AM EST
  18. Stocks Hitting 52-Week Highs

    Benzinga | Nov. 4, 2013 | 10:35AM EST
  19. Stocks Hitting 52-Week Highs

    Benzinga | Sep. 4, 2013 | 10:16AM EST
  20. Benzinga's Top Pre-Market Gainers

    Benzinga | Aug. 1, 2013 | 08:17AM EST
  21. Affymetrix to Undertake Restructuring, Sees 100 Employees Leaving; Offers Prelim. Q4 Sales

    Benzinga | Jan. 8, 2013 | 10:04AM EST
  22. Affymetrix Inc. Reports Operating Results (10-Q)

    GuruFocus | Nov. 6, 2012 | 11:37AM EST
  23. Highs & Lows: Affymetrix, AIG, Akamai Technologies, and Intersil

    SchaeffersResearch | Oct. 8, 2012 | 12:59PM EST
  24. Dell, TIM Participacoes Among Stocks falling to Annual Lows Thursday

    FoxBusiness | Aug. 23, 2012 | 06:31AM EST
  25. Affymetrix Inc. (AFFX) CFO Timothy C Barabe buys 10,000 Shares

    GuruFocus | Aug. 21, 2012 | 13:23PM EST
  26. Affymetrix Inc. Reports Operating Results (10-Q)

    GuruFocus | Aug. 9, 2012 | 13:33PM EST
  27. Affymetrix Announces Expansion of QuantiGene® ViewRNA License for in vitro Diagnostics and Becomes Exclusive Licensee for Chromogenic Applications

    Benzinga | Aug. 1, 2012 | 01:35AM EST
  28. UPDATE: JP Morgan Downgrades Affymetrix to Underweight

    Benzinga | Jul. 11, 2012 | 02:11AM EST
  29. Walgreen, JC Penney Among Stocks Down on Above-average Volume Tuesday

    FoxBusiness | Jun. 19, 2012 | 06:32AM EST
  30. Affymetrix Announces Proposed $105M Offering of Convertible Senior Notes Due 2019

    Benzinga | Jun. 18, 2012 | 10:21AM EST
  31. Affymetrix Inc. Reports Operating Results (10-K)

    GuruFocus | Feb. 28, 2012 | 11:19AM EST
  32. UPDATE: Deutsche Bank Lowers Target on Affymetrix to $6

    Benzinga | Feb. 9, 2012 | 04:10AM EST
  33. UPDATE: Deutsche Bank Upgrades Affymetrix to Buy

    Benzinga | Jan. 25, 2012 | 02:52AM EST
  34. Deutsche Bank Upgrades Affymetrix to Buy

    Benzinga | Jan. 25, 2012 | 02:50AM EST
  35. Affymetrix and BGI Enter Strategic Collaboration to Co-Develop and Commercialize Genomic Microarrays for the Agricultural Community

    Benzinga | Jan. 13, 2012 | 02:01AM EST
  36. Just What The Doctor Ordered: 4 ETFs For Biotech M&A

    Benzinga | Jan. 9, 2012 | 08:49AM EST
  37. UPDATE: JP Morgan Upgrades Affymetrix to Neutral

    Benzinga | Jan. 4, 2012 | 03:50AM EST
Trading Center